Due to lack of product commercialization, lack of profit, an...

Due to lack of product commercialization, lack of profit, and gradual loss of market liquidity, Ricoh Biotech's future is uncertain. The challenges facing Ricoh Biotech include speeding up the commercialization process of vaccine programs, increasing cash flow, and increasing investor interest in them.